Having in mind that metastasis is linked with the activation of E2F1-governed GRNs, we applied a transcriptomics-aided bioinformatics workflow, followed by virtual drug screening to comprehensively characterize novel therapeutic targets in melanoma and predict their corresponding drug inhibitors. This evidence concerns the gene E2F1 and melanoma.